A clean photometric method for the determination of Losartan potassium (cas 12475-99-8) in pharmaceuticals exploiting light scattering effect and employing a multicommuted flow analysis approach
-
Add time:08/16/2019 Source:sciencedirect.com
This paper describes an environmentally friendly procedure for the determination of Losartan potassium (cas 12475-99-8) (Los-K) in pharmaceuticals. The photometric method was based on the light scattering effect due to particles suspension, which were formed by the reaction of Los-K with Cu (II) ions. The method was automated employing a multicommuted flow analysis approach, implemented using solenoid mini-pumps for fluid propelling and a homemade LED based photometer. Under the optimized experimental conditions, the procedure showed a linear relationship in the concentration range of 23.2–417.6 mg L–1 (r=0.9997, n=6), a relative standard deviation of 1.61% (n=10), a limit of detection (3.3*σ) estimated to be 12.1 mg L–1, and a sampling rate of 140 determinations per hour. Each determination consumed 12 µg of copper (II) acetate and generated 0.54 mL of waste.
We also recommend Trading Suppliers and Manufacturers of Losartan potassium (cas 12475-99-8). Pls Click Website Link as below: cas 12475-99-8 suppliers
Prev:Computational study of influence of diffuse basis functions on geometry optimization and spectroscopic properties of Losartan potassium (cas 12475-99-8)
Next:A statistical study on the development of micro particulate sustained drug delivery system for Losartan potassium (cas 12475-99-8) by 32 factorial design approach) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Molecular insight into atypical instability behavior of fixed-dose combination containing amlodipine besylate and Losartan potassium (cas 12475-99-8)08/19/2019
- Formulation and evaluation of sublingual tablets of Losartan potassium (cas 12475-99-8)08/18/2019
- A statistical study on the development of micro particulate sustained drug delivery system for Losartan potassium (cas 12475-99-8) by 32 factorial design approach08/17/2019
- Computational study of influence of diffuse basis functions on geometry optimization and spectroscopic properties of Losartan potassium (cas 12475-99-8)08/15/2019
- Significance of Metabolites in Bioequivalence: Losartan potassium (cas 12475-99-8) as a Case Study08/14/2019
- Utilizing Guar Gum for Development of “Tabs In Cap’ System of Losartan potassium (cas 12475-99-8) for Chronotherapeutics08/13/2019
- Design and evaluation of controlled release Losartan potassium (cas 12475-99-8) microcapsules08/12/2019
- Comparison of Fixed-dose Combinations of Amlodipine/Losartan potassium (cas 12475-99-8)/Chlorthalidone and Amlodipine/Losartan potassium (cas 12475-99-8) in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan potassium (cas 12475-99-8): A Randomized, Double-blind, Multicenter, Phase III Study08/11/2019
- Modulating effect of Losartan potassium (cas 12475-99-8) on the mutagenicity and recombinogenicity of doxorubicin in somatic cells of Drosophila melanogaster08/10/2019
-
Health and Chemical more >
-
Related Products
- Losartan carboxylic acid
- Losartan potassium
- Potassium (2S,3S)-3-(ethoxycarbonyl)oxirane-2-carboxylate
- Potassium (4-formylphenyl)trifluoroborate
- Potassium (bromomethyl)trifluoroborate
- Potassium (R)-((3-ethoxy-1-methyl-3-oxoprop-1-enyl)amino)(4-hydroxyphenyl)acetate
- Potassium (R)-(4-hydroxyphenyl)((3-methoxy-1-methyl-3-oxoprop-1-enyl)amino)acetate
- Potassium (R)-[(3-ethoxy-1-methyl-3-oxoprop-1-enyl)amino]phenylacetate
- Potassium [(cyanomethyl)thio]acetate
- Potassium 1,2,3,6-tetrahydro-5-nitro-2,6-dioxopyrimidine-4-carboxylate


